PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 13, 2003 Subscribe to this News Feed    
 

Redasoft and ScienceServe Sign Distribution Agreement for Visual Cloning Software in Germany, Switzerland, and Austria.

Redasoft and ScienceServe Sign Distribution Agreement for Visual Cloning Software in Germany, Switzerland, and Austria.

    

        

            Redasoft and ScienceServe Sign Distribution Agreement for Visual Cloning Software in Germany, Switzerland, and Austria.

        

         Toronto, ON - February 11, 2003 - Redasoft, a global provider of drug discovery productivity enhancement software for the life science research community, and ScienceServe, a leading distributor of scientific software, today announced an agreement for the distribution of Visual Cloning, Redasofts desktop genetic map drawing and sequence analysis software package, for the German, Swiss, and Austrian markets.
        
        

           "The biotechnology market in Germany is second only to that of the United Kingdom in the European market," said Danny Reda, Redasofts President and Chief Executive Officer. "The German market consists of approximately 500 biotechnology companies, grew by 21% to $6 Billion, and is expected to grow to 700 companies and $12 Billion by 2005. We are therefore extremely pleased to partner with ScienceServe to help our customers in Germany and surrounding markets."
        
        

           Redasoft Visual Cloning is an industry leading software suite that enables increased efficiency and productivity in drug discovery research. Key features of the software include exceptional graphics, extensive web integration, advanced restriction analysis, open reading frames search, primer design, a sequence viewer, subsequence search, and an intuitive user interface.
        
        

            About ScienceServe
        
        

           ScienceServe GmbH, a German company located in Pegnitz, Bavaria, was founded in 1994 for the purpose of scientific software and information distribution, consulting and training services for the chemical and pharmaceutical industry. The well established company is one of the leading resellers of scientific desktop software, chemical databases, analytical data management, enterprise solutions and computational chemistry software. With more than 1000 customers in all major chemical and pharmaceutical companies as well as academic research organizations, ScienceServe is one of the principal providers of chemistry software in Germany, Austria, Switzerland and Eastern Europe. Additional information about ScienceServe can be found at http://www.scienceserve.com">http://www.scienceserve.com.
        
        

            About Redasoft

            Based in Toronto, Canada, Redasoft is a global provider of drug
            discovery productivity enhancement software for the life science
            research community. Founded in 1997, Redasofts mission is to be an
            enabling solutions provider of intuitive, easy to use integrating
            software and services for drug discovery research. Redasoft's
            software empowers life science researchers to visualize genetic
            data, analyze biomolecules, and develop experiment strategies to
            learn more about the fundamental building blocks of life. Additional
            information about Redasoft can be found at
            http://www.redasoft.com">http://www.redasoft.com.

        

            Contact
        

         For further information, contact Evan Carmichael at ecarmichael@redasoft.com.
      
    
    

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Andrew Howitt
Redasoft
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.